Поиск
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.

Список литературы

  1. Детская нефрология: практическое руководство под ред. Э. Лоймана, А. Н. Цыгина, А. А. Саркисяна. М.: Литтерра, 2010, 400 с.
  2. Alper S.L. Familial renal tubular acidosis. J. Nephrol. 2010; 23 Suppl 16: 57-76.
  3. Amin N., Alvi N.S., Barth J.H. et al. Pseudohypoaldosteronism type 1: clinical features and management in infancy. Endocrinol. Diabetes Metab. Case Rep. 2013; 2013:130010
  4. Batlle D., Haque S.K. Genetic causes and mechanisms of distal renal tubular acidosis. Nephrol. Dial. Transplant. 2012; 27(10): 3691-3704
  5. Carpenter T.O., Imel E.A., Holm I.A. et al. A clinician guide to X-linked hypophosphatemia. J. Bone Miner. Res. 2011; 26(7): 1381-1388
  6. Carpenter T.O., Olear E.A., Zhang J.H. et al. Effect of paricalcitol on circulating parathyroid hormone in X-linked hypophosphatemia: a randomized, double-blind, placebo- controlled study. J. Clin. Endocrinol. Metab. 2014; 99(9): 3103-3111
  7. Elmonem M.A., Veys K.R., Soliman N.A. et al. Cystinosis: a review. Orphanet Journal of Rare Diseases. 2016; 11:47
  8. Emma F., Nesterova G., Langman C. et al. Nephropathic cystinosis: an international consensus document. Nephrol. Dial. Transplant. 2014; 29 Suppl. 4: 87-94
  9. Fremont O.T., Chan J.C.M. Understanding Bartter syndrome and Gitelman syndrome. World Journal of Pediatrics. 2012; 8(1): 25-30
  10. Garovic V.D., Hilliard A.A., Turner S.T. Monogenic forms of low-renin hypertension. Nat. Clin. Pract. Nephrol. 2006; 2(11): 624-630
  11. Haque S.K., Ariceta G., Batlle D. Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies. Nephrol. Dial. Transplant. 2012; 27(12): 4273-4287
  12. Katzir Z., Dinour D., Reznik-Wolf H. et al. Familial pure proximal renal tubular acidosis – a clinical and genetic study. Nephrol. Dial. Transplant. 2018; 23(4): 1211-1215
  13. Knoers NVAM, Levtchenko E.N. Gitelman syndrome. OJRD. 2008; 3(1): 22
  14. Krämer B.K, Bergler T., Stoelcker B., Waldegger S. Mechanisms of Disease: the kidney- specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance. Nat. Clin. Pract. Nephrol. 2008; 4(1): 38-46.
  15. Langman C.B., Greenbaum L.A., Grimm P. et al. Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrate. J. Pediatr. 2014; 165(3): 528-533.
  16. Langman C.B., Greenbaum L.A., Sarwal M. et al. A randomized controlled crossover trial whith delayed-release cysteamine bitartrat in nephropathic cystinosis: Effectiveness on white blood cell cystine levels and comparison of safety. Clin. J. Am. Soc. Nephrol. 2012; 7(7): 1112-1120
  17. Lee J.Y., Imel E.A. The Changing Face of Hypophosphatemic Disorders in the FGF-23 Era. Pediatr. Endocrinol. Rev. 2013; 10(0 2): 367–379.
  18. Linglart A., Biosse-Duplan M., Briot K. et al. Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr. Connect. 2014; 3(1): 13-30
  19. Mayan H., Vered I., Mouallem M. et al. Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J. Clin. Endocrinol. Metab. 2002; 87(7): 3248-3254.
  20. Prié D. Familial renal glycosuria and modifications of glucose renal excretion. Diabetes Metab. 2014; 6 Suppl. 1: 12-16.
  21. Puricelli E., Bettinelli A., Borsa N. et al. Long-term follow-up of patients with Bartter syndrome type I and II. Nephrol. Dial. Transplant. 2010; 25(9): 2976-2981.
  22. Riepe F.G. Clinical and Molecular Features of Type 1 Pseudohypoaldosteronism. Horm. Res. 2009; 72 (1): 1-9.
  23. Santer R, Calado J. Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target. Clin. J. Am. Soc. Nephrol.. 2010; 5(1): 133-141.
  24. Schrier R.W. Body water homeostasis: clinical disorders of urinary dilution and concentration. J. Am. Soc. Nephrol. 2006 (17): 1820-1832
  25. Sirac C., Bridoux F, Essig M, Devuyst O, Touchard G, Cogne M. Toward understanding renal Fanconi syndrome: step by step advances through experimental models. Contrib. Nephrol. 2011; 169: 247–261.
  26. Soylu A., Kasap B., Ogun N., Ozturk Y., Turkmen M., Hoefsloot L., Kavukcu S. Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus. Pediatr. Nephrol. 2005; 20:1814–1817.
  27. Wesche D., Deen PMT., Knoers NVAM. Congenital nephrogenic diabetes insipidus: the current state of affairs. Pediatr. Nephrol. 2012 (27): 2183–2204.
  28. Zivicnjak M., Schnabel D., Staude H. et al. Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion. J. Clin. Endocrinol. Metab. 2011; 96(12): 2097-2105.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу